Tag: Drug Quality Control

Kazakhstan reaches important milestone of its National Drug Policy development

At the end of 2017, the Minister of Health of the Republic of Kazakhstan signed the order approving the Kazakhstan National Formulary

Russian President signs the Federal Law on introduction of drug labeling

Russian President Vladimir Putin signed the Federal Law “On amendments to the Federal law "On Circulation of medicines.”

The Federation Council of Russia ratifies the MEDICRIME Convention

Russian senators have approved the Federal Law “On ratification of the Council of Europe Convention on the counterfeiting of medical products”

Russia ratifies the Convention on counterfeiting of medicinal products

The State Duma ratified the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health

FAS Russia reports on the most frequent violations in healthcare sector

The Federal Antimonopoly Service of Russia participates in the reform of control and oversight activities

Dark web drug market evolves at a rapid pace in Europe

dark web
The illegal drug trade on the dark web is growing rapidly despite authorities shutting down major market sites

WHO published its study report on falsified medical products

An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO

EMA launched an improved version of EudraVigilance information system

The European Medicines Agency has launched a new and improved version of EudraVigilance, the European information system

Kazakhstan’s Center for Expertise of Medicines joined IPRF and IGDRP

kazakhstan drug quality control
The meetings of the Management Committee of IPRF and the Steering Committee of IGDRP approved the admission of the Kazakhstan’s Center to IPRF and IGDRP

Russian State Duma approves the drug labeling bill in the first reading

russian state duma
Russia introduces total control over the quality of drugs

FDA allows eight European authorities to conduct GMP inspections

us eu
U.S. Food and Drug Administration will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities

The Chinese Government set new rules to speed up drug approvals

china street
China will encourage innovation in drugs and medical equipment by expanding the reform of review and approval system in the medical sector

EMA started a survey to understand the awareness about side effects of medicines

european medicines agency
The European Medicines Agency (EMA) launches survey to assess whether patients and doctors are aware of the arrangements for reporting of side effects.

Roszdravnadzor detected and recalled 2 counterfeit drugs in H1

fake drugs
The Federal Service for Surveillance in Healthcare released the results of state control (surveillance) over the circulation of medicinal products for H1 2017

Roszdravnadzor seizes counterfeit Xymelin

the Federal Service for Surveillance in Healthcare informs on the need to withdraw from circulation a counterfeit medicinal product “Xymelin

Bayer recieved EU marketing authorization for Stivarga

Bayer announced the European Commission (EC) has granted marketing authorization for Stivarga® (regorafenib)